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Diabetes mellitus, type 2
Process assessment, health care
a  b  s  t  r  a  c  t
Aims:  To explore  variation  in  general  practitioners’  (GPs’)  performance  of six recommended  procedures
in  type  2  diabetes  patients  <75  years  without  cardiovascular  disease.
Methods:  Cross-sectional  study  of  quality  of  diabetes  care  in  Norway  based  on  electronic  health  records
from  2014.  GPs  (clustered  in  practices)  were  divided  in  quintiles  based  on  a  composite  measure  of  per-
formance  of  six  processes  of  care.  We  fitted  a multilevel  partial ordinal  regression  model  to identify  GP
factors associated  with  being  in quintiles  with  better  performance.
Results:  We  identified  6015  type  2 diabetes  patients  from  275  GPs  in 77 practices.  The  GPs  performed  on
average  63.4%  of  the procedures;  on  average  46%  in  the  poorest  quintile  to 81% in the  best  quintile  with
a  larger  range  in  individual  GPs.  After adjustments,  use of  a structured  follow-up  form  was  associated
with  GPs  being  in  upper  three  quintiles  (OR  12.4  (95%  CI 2.37–65.1).  Routines  for  reminders  were  asso-Quality improvement
Primary health care
Quality indicators, health care
Guideline adherence
ciated  with  being  in a  better quintile  (OR  2.6 (1.37–4.92).  GPs’  age  >60  years  and  heavier  workload  were
associated  with  poorer  performance.
Conclusion:  We  found  large  variations  in  GPs’  performance  of processes  of  care.  Factors  reflecting  structure
and  workload  were  strongly  associated  with  performance.
©  2020  The  Authors.  Published  by  Elsevier  Ltd on  behalf  of  Primary  Care  Diabetes  Europe.








Type 2 diabetes is a complex disease placing high demands on
both patients and health care professionals. General practitioners
are supposed to counsel patients in self-management and lifestyle
modifications, monitor risk factors, screen for and treat com-
plications, pursue individualized treatment targets and manage
medications for hyperglycemia, hypertension and hyperlipidemia.
A gap in the quality between the recommended and actual care
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or type 2 diabetes patients is well documented [1,2], as well as
ariations in quality within provider levels, regions and countries
3–9]. Some variation might reflect patient-centered care, whereas
ome variation is unwarranted and cannot be fully explained by dis-
ase severity or patient preferences [10]. Identifying the sources of
nwarranted variation can provide a basis for quality improvement
trategies.
According to Donabedian’s model of quality of care, structural
actors influence processes of care, which also has an influence
n outcomes. Therefore, the quality of care could be measured by
ssessing these three aspects: structure, process and outcome [11].
otential strategies to improve quality in diabetes care [12] or to
ncrease guideline adherence [13], include interventions within the
etes Europe. This is an open access article under the CC BY-NC-ND license (http://
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structural aspect, addressing both material and human resources
and organizational structure.
In assessing provider-level variation in the quality of care for
type 2 diabetes patients, the process measures, rather than the clin-
ical outcomes, are more likely to reflect the physician’s working
style [14,15]. Process measures in diabetes care also show larger
variation at the provider levels than clinical outcomes [16,17].
Furthermore, these measures have been regarded as high-impact
quality indicators in primary health care [18].
In Norway, type 2 diabetes patients are primarily treated in
general practice. We  recently reported that processes of care for
diabetes patients were suboptimal with, for example, only one third
of the patients having had a measurement of albuminuria or foot
examination during the past 15 months [2].
Thus, our primary objective was to explore the variation in
the general practitioners’ (GPs’) overall performance of six rec-
ommended procedures and to identify GP and practice factors
associated with the performance of these procedures in a popula-
tion of type 2 diabetes patients aged <75 years without diagnosed
cardiovascular disease (CVD). We  hypothesized a large variation
between the GPs, and that structural factors were associated with
the quality of care, in line with Donabedian’s model [11].
2. Research design and methods
The ROSA 4 study (acronym for participating regions) is a
population-based cross-sectional study of the quality of care in
2014 for diabetes patients from general practice in five of 11 coun-
ties in Norway. In total, 77 practices (73%) with 282 GPs (77%)
agreed to participate.
All GPs within each practice participated, and 11 428 dia-
betes patients 18 years or older were identified in their electronic
health records (EHR). Details about recruitment and data collec-
tion have been previously published [2]. Briefly, research nurses
manually validated the diabetes diagnoses and collected patient
data (time of diagnosis, blood pressure, screening procedures and
complications) from the EHRs. Laboratory results and informa-
tion about prescribed medications were automatically extracted.
Furthermore, questionnaire data were collected about the charac-
teristics of the GPs, the practices and routines for management and
the follow-up of diabetes patients (data from 100% of practices,
and from 99% of GPs) [19]. Patient information about education
level and ethnicity was obtained by linkage to data from “Statistics
Norway”. The Regional Ethics committee approved the study.
2.1. Setting
Norway has universal health care with small patient co-
payments. Almost all citizens are registered with an individual
GP. The GPs are organized in practices with varying size and are
paid according to the number of patients listed with the individ-
ual GP, consultations and types of procedures performed. GPs get
no external reimbursement for GP staff members but there is a
small economic incentive for a yearly diabetes control with rec-
ommended procedures. No benchmarking, pay-for-performance
initiatives or universal chronic care models have been introduced
by the national health authorities. Neither is there a tradition for
structured population management.
2.2. Outcome
Our primary outcome (at GP level) was a summary measure
for each GP, reflecting the performance of six procedures recom-
mended in type 2 diabetes care: measurements of HbA1c, LDL
cholesterol, albuminuria, blood pressure and recorded foot exam-




496ig. 1. Distribution and quintiles of the mean proportion of procedures for each
f  the 275 general practitioners. Standard error bars represent the variation of the
umber of procedures in the patients of each general practitioner. Q = quintile.
ecember 31, 2014); and recorded eye examination in the past
0 months (July 1, 2012–December 31, 2014). For each GP, the
roportions of patients receiving each of the six procedures were
alculated and the scores were averaged across all process indica-
ors, resulting in a process performance indicator average [20]. The
Ps were divided into quintiles based on their indicator average to
haracterize groups of better- and worse-performing GPs.
.3. Sample
For this project there was  a fixed available sample of GPs and
atients. Of the 11 428 diabetes patients, 10 079 had type 2 diabetes
nd were registered with a GP (flow chart, Supplementary Fig. 1).
e  excluded patients ≥75 years and those with CVD to study GP
ehavior in patients with potentially most to gain (balancing effect
ersus harm) [21,22]. We  also excluded 7 GPs with <5 type 2 dia-
etes patients, resulting in a study sample of 77 GP practices (100%
f enrolled) 275 GPs (98% of all enrolled) and 6015 patients (60% of
ype 2 diabetes patients).
.4. Variables
We  included available variables relevant for diabetes quality
rom the literature, and variables potentially associated with qual-
ty.
.4.1. GP variables
Age; gender; specialist status; country of birth; number of type
 diabetes patients; work load (number of registered patients on
ach GP’s list divided by number of clinical days per week); use
f an electronic follow-up form (i.e., the form was  applied in ≥10
atients or >50% of their listed type 2 diabetes patients).
.4.2. GP practice variables
County; number of GPs in the practice; practices with nurses;
taff involvement in diabetes care (assigned ≥2 tasks: dietary
uidance, tasks in the annual review, patient education (glucose
easurements, injection techniques, and/or foot care)); and rou-
ines for reminding patients of yearly diabetes control.
.4.3. Patient variables
Age; gender; duration of diabetes; ethnicity (country of birth);
ducation level; levels of HbA1c, LDL-cholesterol, albuminuria and
ystolic blood pressure; recordings of foot examination (foot pulses

















Descriptive general practitioner (GP) and practice characteristics within quintiles.
Total Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 p for trend
Number of GPs in each quintile 275 54 56 55 55 55
Number  of patients in each quintile 6015 1174 1160 1262 1195 1224
Performance of procedures
Proportion of procedures performed 63.4 45.8 (43.7–47.8) 56.5 (55.8–57.1) 63.5 (63.1–63.9) 69.6 (69.0–70.2) 81.3 (79.8–82.9)
LDL  measured* 85.3 65.9 (59.1–72.8) 85.7 (82.8–88.6) 89.1 (86.1–92.1) 90.0 (87.6–92.4) 95.6 (94.0–97.2)
Blood  pressure measured* 85.8 74.6 (69.8–79.4) 83.4 (80.6–86.3) 87.9 (85.3–90.6) 88.5 (86.3–90.7) 94.1 (92.2–96.1)
HbA1c  measured* 90.0 80.5 (76.1–84.8) 87.3 (85.0–90.0) 91.0 (89.0–93.0) 90.4 (88.5–92.4) 95.5 (93.9–97.0)
Albuminuria assessed* 34.6 8.5 (9.1–13.8) 17.4 (12.8–22.1) 32.6 (26.8–38.5) 48.3 (43.3–53.3) 66.1 (60.6–71.6)
Retinopathy screening documented* 54.8 33.7 (29.1–38.3) 48.2 (44.0–52.4) 53.1 (48.8–57.4) 64.1 (60.4–67.8) 74.5 (70.8–78.2)
Foot  examination recorded* 30.9 11.5 (9.1–13.8) 16.9 (14.2–19.6) 27.1 (23.1–31.0) 36.4 (32.4–40.5) 62.3 (56.4–68.2)
Characteristics of the GPs
Proportion of GP age groups
<40 years 22.9 11.1 (5.0–22.8) 28.6 (18.2–41.9) 27.3 (17.0–40.6) 30.9 (20.0–44.4) 16.4 (8.7–28.8) 0.491
40−60  years 53.5 46.3 (33.4–59.7) 48.2 (35.4–61.3) 50.9 (37.8–63.9) 50.9 (37.8–63.9) 70.9 (57.5–81.5) 0.015
>60  years 23.6 42.6 (30.0–56.2) 23.2 (13.9–36.2) 21.8 (12.7–34.8) 18.2 (10.0–30.8) 12.7 (6.1–24.6) < 0.001
Female  GPs 44.7 29.6 (18.9–43.2) 48.2 (35.3–61.3) 41.8 (29.5–55.3) 50.9 (37.8–63.9) 52.7 (39.5–65.6) 0.022
GP  specialists 67.6 61.1 (47.4–73.2) 62.5 (49.1–74.3) 72.7 (59.4–83.0) 63.6 (50.1–75.3) 78.2 (65.2–87.3) 0.077
GPs  born in Norway 81.4†  77.8 (64.6–87.0) 78.6 (65.8–87.5) 89.1 (77.6–95.1) 75.9 (62.6–85.6) 85.5 (73.3–92.6) < 0.001
Workload (listed patients per clinical day)
<250 patients 25.1 7.4 (2.8–18.3) 23.2 (13.9–36.2) 20.0 (11.3–32.8) 41.8 (29.5–55.3) 32.7 (21.6–46.3) < 0.001
250−350  patients 54.9 55.6 (42.0–68.3) 51.8 (38.7–64.6) 61.8 (48.3–73.8) 56.4 (42.9–68.9) 49.1 (36.1–62.2) 0.696
>350  patients 20.0 37.0 (25.2–50.7) 25.0 (15.3–38.1) 18.2 (10.0–30.8) 1.8 (0.2–12.1) 18.2 (10.0–30.8) < 0.001
Number  of type 2 diabetes patients listed
<20 T2D¤ patients 50.2 48.1 (35.1–61.5) 55.4 (42.1–67.9) 49.1 (36.1–62.2) 47.3 (34.4–60.5) 50.9 (37.8–63.9) 0.898
20−35  T2D patients 38.6 40.7 (28.4–54.4) 35.7 (24.2–49.2) 41.8 (29.5–55.3) 43.6 (31.1–57.1) 30.9 (20.0–44.4) 0.575
>36  T2D patients 11.3 11.1 (5.0–22.8) 8.9 (3.7–19.9) 9.1 (3.8–20.3) 9.1 (3.8–20.3) 18.2 (10.0–30.8) 0.286
GP  uses follow-up form 24.7 0 7.1 (2.7–17.7) 27.3 (17.0–40.6) 30.9 (20.0–44.4) 58.2 (44.7–70.5) < 0.001
Practice  characteristics
GPs with nurse (incl. diabetes nurse) 43.6 27.8 (17.4–41.3) 39.3 (27.3–52.7) 45.5 (32.7–58.8) 43.6 (31.1–57.1) 61.8 (48.3–73.8) < 0.001
Staff  involved in diabetes care 34.9 14.8 (7.6–27.0) 25.0 (15.4–38.0) 41.8 (29.6–55.2) 45.5 (32.8–58.7) 47.3 (34.5–60.4) < 0.001
Routine  for reminders of yearly control 24.9 7.4 (2.8–18.3) 28.6 (18.2–41.9) 25.5 (15.6–38.7) 23.6 (14.1–36.8) 32.7 (21.6–46.3) 0.013
County  (proportion in each quintile)
Oslo/Akershus 35.6 57.4 (43.9 - 69.9 48.2 (35.5–61.2) 34.5 (23.2–48.0) 27.3 (17.1–40.5) 10.9 (5.0–22.3) < 0.001
Hordaland 14.9 16.7 (8.8–29.2) 25.0 (15.3–38.1) 16.4 (8.7–28.8) 5.5 (1.7–15.8) 10.9 (4.9–22.4) 0.040
Nordland 26.9 11.1 (5.0–22.8) 21.4 (12.5–34.2) 16.4 (8.7–28.8) 41.8 (29.5–55.3) 43.6 (31.1–57.1) < 0.001
Rogaland 22.6 14.8 (7.5–27.1) 5.4 (1.7–15.5) 32.7 (21.6–46.3) 25.5 (15.6–38.7) 34.6 (23.1–48.1) < 0.001
Size  of practice
1−2 GPs 14.6 20.4 (11.6–33.2) 8.9 (3.8–19.8) 14.5 (7.4–26.5) 12.7 (6.2–24.4) 16.4 (8.7–28.6) 0.795
3−4  GPs 34.6 31.5 (20.5–45.0) 28.6 (18.3–41.7) 27.3 (17.1–40.5) 41.8 (29.6–55.2) 43.6 (31.2–56.9) 0.063
5−9  GPs 50.9 48.1 (35.2–61.4) 62.5 (49.2–74.2) 58.2 (44.8–70.4) 45.5 (32.8–58.7) 40.0 (27.9–53.4) 0.113
Proportions within each quintile in % with 95% confidence intervals, trend. The quintiles are based on each GP’s (n = 275) proportion of performance of six procedures and measurements in their patients. *Average proportion of
patients  who had these procedures performed. †  n = 274. ¤ Type 2 diabetes.
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Table  2
Regional differences in use of follow-up form (2014). n = 275 GPs.
Region n Users (%) Non-users (%)
Oslo/Akershus 46 5 (5.1) 93 (94.9)
Hordaland 41 5 (12.2) 36 (87.8)
Fig. 2. a) Average proportions (%) (with 95% confidence intervals) of performed























Nordland 74 33 (44.6) 41 (55.4)
Rogaland 62 25 (40.3) 37 (59.7)
medications from the last 15 months: glucose-lowering, lipid-
lowering and antihypertensive medications.
2.5. Statistical methods
The GPs were the unit of analysis (level 1), practices were level
2, accounting for clustering of GPs in practices. We  used descriptive
statistics with means and proportions with 95% confidence inter-
vals (CI). Differences across the quintiles were established from
tests for trends (prop.trend.test in R for proportions, and nptrend
in Stata for continuous variables).
We first tried to fit a multilevel ordinal logistic model to identify
factors associated with GPs being in different quintiles of pro-
cess performance, as the quintiles represent an ordered categorical
dependent variable. The assumption of proportionality between
quintiles in an ordinal model was violated for some variables. Thus
we fitted a multilevel partial ordinal logistic model with random
effects at GP practice level using gologit2 [23]. To check for mul-
ticollinearity, we calculated variance inflation factors. Continuous
GP and practice factors (exposure variables) were grouped in cat-
egories driven by the distribution of the data. Patient level factors
were aggregated at GP level as means or proportions, represent-
ing case-mix adjustments (confounders). For variables fulfilling the
assumption of proportionality, we obtained four equal OR esti-
mates in four binary models representing the odds of being higher
than a certain quintile. For the remaining variables we obtained
different ORs for the four binary models comparing different com-
binations of quintiles. We fitted one model including only GP
characteristics (supplementary table S2) whereas the main model
also included aggregated patient characteristics (Table 3). Among
the 275 participating GPs, we could include 274 in the adjusted
models, so missingness was a negligible problem.
For the multivariate analysis, independent variables with p ≤
0.2 in univariate analysis were included. The capital region (Oslo
and the surrounding Akershus County) were merged as both had
very few GPs using follow-up form and characteristics elsewhere
were similar. We  checked for interactions and found interactions
between the variables “county” and “nurse”, and “county” and”
use of follow-up forms”. However, the model fit, assessed by the
Akaike Information Criterion, did not improve with interactions
terms included in the models.
Intracluster correlation (ICC) estimates were obtained to
explore the variance in the GP procedure performance that was
attributable to the GP practice level, intended to evaluate how
strongly the GPs within each practice resemble one another.
Analyses were performed in StataSE 16 (StataCorp, College Sta-
tion, USA) and R 3.4.3 (The R Foundation for Statistical Computing,
Vienna, Austria) and the significance level was set at  ̨ = 0.05.
3. Results
Each quintile of GP performance included 54–56 GPs and
1160–1262 patients (Table 1). On average, the GPs performed 63.4%
of the six procedures on their patients, ranging from 7.8% to 96.3%
between the individual GPs (Table 1 and Fig. 1). GPs in quintile 1
on average performed 45.8% of the procedures, while GPs in quin-





498)  Average proportions (%) (with 95% confidence intervals) of performed foot exam-
nation, measurement of albuminuria and recorded eye examination within the
uintiles.
uintiles 2–5 performed measurements of HbA1c, blood pressure
nd LDL-cholesterol on more than 80% of the patients, significantly
ore than GPs in quintile 1 (Fig. 2a). The variation between the
uintiles was largest for the microvascular screening procedures
Fig. 2b). On average, the GPs in quintile 1 measured albuminuria
n only 8.5% (95% CI 9.1–13.8) of their patients compared with 66.1%
60.6–71.6) for GPs in quintile 5.
Consistent patterns across the quintiles were found for several
P characteristics (Table 1), with a strong trend for the use of an
lectronic follow-up form – from 0% in quintile 1 to 58.2% in quintile
 (p < 0.001). Regional variations in the use of a follow-up form is
resented in Table 2.
For patient characteristics, there were some differences across
he quintiles in proportions of ethnic minority groups, medications,
ean HbA1c and LDL levels and estimated 10-year risk of CVD
vents (Supplementary Table S1).
After adjustment for GP and patient factors, the factor most
trongly associated with being in a higher quintile was the use of
 structured form in the follow-up (Table 3). Further, GPs with the
eaviest workload had lower odds of being in a higher quintile,
specially the combined upper two  quintiles, compared to those
ith <250 patients/day. The oldest doctors (61−70 years) had lowerdds of being in a higher quintile compared to GPs between 40
nd 60 years, whereas specialists and GPs in larger practices were
ess likely to be in the worst quintile. GPs in the capital region
Oslo/Akershus) performed worse across all quintiles, whereas GPs
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Table  3
Factors associated with being in better quintiles of general practitioner performance (2014).
GP characteristics Q2-Q5 vs Q1 Q3-Q5 vs Q1-Q2 Q4-Q5 vs Q1-Q3 Q5 vs Q1-Q4
GP gender (ref. male) 1.38 (0.78–2.43) 1.38 (0.78–2.43) 1.38 (0.78–2.43) 1.38 (0.78–2.43)
Specialist (ref. no)† 4.94 (1.85–13.2)*** 3.38 (1.39–8.19)** 1.10 (0.49–2.47) 0.51 (0.14–1.79)
Workload (ref. <250 patients/clinical day) 1 1 1 1
250−350  patients 0.33 (0.14−0.75)** 0.33 (0.14−0.75)** 0.33 (0.14−0.75)** 0.33 (0.14−0.75)**
>350 patients†  0.18 (0.06−0.52)** 0.08 (0.03−0.22)*** 0.05 (0.01−0.15)*** 0.98 (0.22–4.35)
Number of type 2 diabetes patients listed (ref <20) 1 1 1 1
21−35  1.24 (0.67–2.30) 1.24 (0.67–2.30) 1.24 (0.67–2.30) 1.24 (0.67–2.30)
>36  3.38 (1.18–9.72* 3.38 (1.18–9.72* 3.38 (1.18–9.72* 3.38 (1.18–9.72*
GP  country of birth (ref. Norway)† 1.24 (0.43–3.55) 0.40 (0.15–1.12) 1.43 (0.52–3.90) 0.30 (0.07–1.26)
Age  of GPs (ref. 40−60 years) 1 1 1 1
27−39  years†  5.62 (1.43–22.0)* 1.51 (0.55–4.10) 0.43 (0.19–1.03) 0.11 (0.03−0.37)***
61−70  years†  0.32 (0.13−0.79)* 0.85 (0.37–1.96) 0.39 (0.18−0.81)* 0.18 (0.06−0.49)**
Follow-up form (ref. non-user)†  ¤ 12.4 (2.37–65.1)** 2.92 (1.30–6.53)* 7.50 (3.12–18.0)***
GP  practice characteristics
County (ref. Nordland) 1 1 1 1
Oslo/Akershus 0.27 (0.10−0.75)* 0.27 (0.10−0.75)* 0.27 (0.10−0.75)* 0.27 (0.10−0.75)*
Hordaland 0.40 (0.10–1.59) 0.40 (0.10–1.59) 0.40 (0.10–1.59) 0.40 (0.10–1.59)
Rogaland†  0.43 (0.08–2.19) 3.66 (1.05–12.7)* 0.97 (0.31–3.06) 2.97 (1.05–8.31)*
Routines for reminders (ref. no) 2.60 (1.37–4.92)** 2.60 (1.37–4.92)** 2.60 (1.37–4.92)** 2.60 (1.37–4.92)**
Staff  involved in diabetes care (ref. no) 0.79 (0.39–1.64) 0.79 (0.39–1.64) 0.79 (0.39–1.64) 0.79 (0.39–1.64)
Size  of practice (ref. 1−2 GPs) 1 1 1
3−4  GPs 2.51 (0.99–6.3) 2.51 (0.99–6.3) 2.51 (0.99–6.3) 2.51 (0.99–6.3)
5−9  GPs†  6.87 (2.52–18.7)*** 2.08 (0.75–5.80) 2.82 (1.08–7.37)* 1.33 (0.47–3.73)
Nurse  employed (ref. no) 0.64 (0.26–1.58) 0.64 (0.26–1.58) 0.64 (0.26–1.58) 0.64 (0.26–1.58)




























level  and ethnicity).
*p < 0.05; **p < 0.01; ***p < 0.001. Q = quintile. ¤There were no users of follow-up 
odds  ratios do not vary between the different comparisons of quintiles).
in practices with routines of reminders performed better across all
quintiles.
Estimates of ICC of 0.5 and 0.34 in the variance component
model and the adjusted model respectively, implied that 34% of
the total variance of the indicator average could be explained by
differences between the practices.
4. Discussion
In the present study we found a consistent pattern of substan-
tial variation in the GPs’ overall performance of six recommended
procedures in type 2 diabetes patients. The average performance
ranged from 46% in the poorest quintile to 81 percent in the best
quintile, with a substantially larger range between individual GPs.
Use of a follow-up-form, patient reminders and more diabetes
patients on GPs’ lists were associated with better performance,
whereas older age of GPs and a large workload and were associated
with poorer performance.
4.1. Strengths and limitations
The ROSA 4 study used high-quality data, manually validated by
research nurses, including information on patient socioeconomic
status and structural factors. GPs and patients are considered rep-
resentative of Norwegian GPs and type 2 diabetes patients [2,24].
We used quality indicators considered to be of high-impact for pri-
mary care [18], recommended in Norwegian diabetes guidelines
since 1995.
Recordings of blood pressure, eye and foot screening were
manually identified in the records and thus not dependent on
a structured documentation in the EHR. Using process measures
instead of patient outcomes reduces the risk of misclassifying the
GPs due to factors over which they may  have little influence, and
a composite measure further increases the reliability [15]. Ana-
lyzing at the GP level rather than the patient level, enabled us to
highlight the large variation between the best-performing and the




499in quintile 1. †Categories that did not fulfil the assumption of proportionality (the
By adjusting for aggregated data on patients’ age, gender,
iabetes duration, education level and ethnicity, much of the het-
rogeneity in the patient lists was  accounted for. For example, some
ategories of patients may  be less willing to attend. Although case-
ix  adjustments might conceal real differences in the quality of
are [16,25], only minor changes in the estimates were observed
hen adding patient characteristics.
However, the cross-sectional design limits inferences about
ausality. Moreover, the reliability of the estimates for performance
s lower in GPs with fewer patients, and we lack information about
he patients’ total comorbidity.
Although we  consider the practices to be fairly representative
or the five counties, practices in two counties (Nordland/Rogaland)
ave been more exposed to quality improvement strategies and
romotion of the use of the follow-up form than other counties in
orway. If some selection bias is operating, the included GPs might
erform slightly better than the average Norwegian GPs.
.2. Comparison with existing literature
Previous studies about variation among GPs in processes of care
or type 2 diabetes patients [3,15,16], mostly report practice level
actors only [8,9,26]. Studies on the GP level are primarily related to
evelopment of methods for “physician profiling” in the UK and the
S [14–16], reporting performance of cost and quality rather than
ndividual physician’s characteristics. Further, direct comparisons
re hampered by different measures for processes of care.
We were unable to identify studies reporting the attribution of
ariance at the GP practice level of diabetes procedures on GP level
ata. One study without GP level data found health center charac-
eristics to account for 36% of the total variation in process measures
8]. In another study at patient level, the primary care provider had
 moderate effect on measurements of HbA1c and lipids, account-
ng for 8–9% of the variation at the patient level, while the clinic
evel accounted for 7–9% of the variation [16].
Many studies have tested different quality improvement strate-
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health care system (through case management, care teams, elec-
tronic tools etc.) generally reduced HbA1c more than strategies
targeting the individual health care providers [12].
Our finding that the GP practice level explained a large part of
the variation in the GPs’ performance of type 2 diabetes processes,
is in line with a report showing that GPs in the same practice were
more likely to act similarly when shared resources were used [27]. A
qualitative study found that the practice characteristics associated
with high performance across clinical indicators were strategies of
clinical quality improvement, care structures supporting screen-
ing, checks and recalls, and a biomedical view of care [28]. We
also found that shared routines of patient reminders for yearly
follow-up, possibly reflecting a common attitude towards struc-
tured care, was important. Neither staff involvement in care nor
the presence of nurses were independently associated with the GP
process performance in our adjusted analysis, in contrast to a meta-
analysis which found that team-based care in diabetes improved
blood glucose, hypertension and lipid levels [29]. In our study, the
association between a higher proportion of nurses and higher quin-
tiles (Table 1) was evened out in the adjusted analysis, probably
by the fact that many GPs in practices with nurses also use the
structured follow-up form.
A larger practice size reduced the GPs’ risk of being in the
lowest-performing quintile. Larger practices might facilitate more
structured care, but the relation to quality of care is not clear, and
other studies have found inconsistent associations of practice size
and quality of diabetes care [30].
Among GP factors, use of an electronic structured diabetes care
follow-up form designed for general practice and semi-integrated
in the electronic health records was strongly associated with bet-
ter performance of processes of care in our study. Few others
have found an effect of a structured form on processes of care
[31], whereas a systematic review found some minor effects on
patient clinical outcomes but did not evaluate effect on guideline
adherence [32]. We  have previously shown an association between
microvascular screening on patient level and the use of a structured
follow-up form in a slightly different patient sample [19].
The inverse association of the workload and the GP performance
indicates that time constraints might influence quality of care, in
line with a large study using administrative data [33]. A qualita-
tive study also found that a large workload and time pressure was
perceived as barriers to delivering appropriate diabetes care [34].
A systematic review, however, found an inconsistent relationship
of workload and diabetes care [30].
Older or more experienced doctors seem to follow guidelines to
a lesser extent [30,35–37], in accordance with our findings, but they
may  add other qualities such as psychosocial skills into diabetes
care [38], not assessed in the present study.
The geographical variation in the use of the follow-up form may
be related to local diabetes plans advocating its use, indicating that
its use not only reflects a special interest in diabetes or an attitude
favoring guideline adherence, and that implementation strategies
are necessary.
In the context of known variation in many aspects of care, it is
likely that there is a variation in the GPs’ working style in health
care systems outside Norway as well. But given the autonomous
role of Norwegian GPs, different structures, incentives and roles
of supportive staff in other health care systems could modify such
variation.
4.3. Implications for research and practiceOur finding of large unwarranted variation clearly demonstrates
the need for quality improvement strategies. Generally, quality
improvement strategies tailored towards the lowest-performing
R
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Ps, or regions where the quality is low, are warranted to reduce
he quality gap.
This cross-sectional study suggests some factors that could
nhance the quality in the worst-performing GPs, but an interven-
ion trial is necessary to confirm an effect.
Further studies should explore if there is a link between the
Ps’ process performance and their patients’ outcomes. A trial with
tructured follow-up forms could also explore its specific role and
hereby enhance the field.
. Conclusion
Large variations between GPs in the performance of diabetes
rocesses of care were found.
Factors facilitating structure in care were associated with better
rocesses of care.
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